- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MN: MANGANESE (II) ION(Non-covalent)
- 16 x GOL: GLYCEROL(Non-functional Binders)
GOL.2: 3 residues within 4Å:- Chain A: H.205, N.208, Q.209
Ligand excluded by PLIPGOL.3: 3 residues within 4Å:- Chain A: Q.19, N.20, K.23
Ligand excluded by PLIPGOL.4: 5 residues within 4Å:- Chain A: S.12, G.15, D.16, T.30, L.249
Ligand excluded by PLIPGOL.5: 3 residues within 4Å:- Chain A: T.44, A.46
- Ligands: ACT.22
Ligand excluded by PLIPGOL.6: 6 residues within 4Å:- Chain A: I.91, G.92, S.94, V.176, S.186, Y.188
Ligand excluded by PLIPGOL.7: 4 residues within 4Å:- Chain A: T.258, L.260, D.261
- Ligands: ACT.15
Ligand excluded by PLIPGOL.8: 2 residues within 4Å:- Chain A: S.94, D.100
Ligand excluded by PLIPGOL.9: 5 residues within 4Å:- Chain A: E.119, R.122, K.123, T.126
- Chain B: R.141
Ligand excluded by PLIPGOL.26: 3 residues within 4Å:- Chain B: H.205, N.208, Q.209
Ligand excluded by PLIPGOL.27: 3 residues within 4Å:- Chain B: Q.19, N.20, K.23
Ligand excluded by PLIPGOL.28: 5 residues within 4Å:- Chain B: S.12, G.15, D.16, T.30, L.249
Ligand excluded by PLIPGOL.29: 3 residues within 4Å:- Chain B: T.44, A.46
- Ligands: ACT.46
Ligand excluded by PLIPGOL.30: 6 residues within 4Å:- Chain B: I.91, G.92, S.94, V.176, S.186, Y.188
Ligand excluded by PLIPGOL.31: 4 residues within 4Å:- Chain B: T.258, L.260, D.261
- Ligands: ACT.39
Ligand excluded by PLIPGOL.32: 2 residues within 4Å:- Chain B: S.94, D.100
Ligand excluded by PLIPGOL.33: 5 residues within 4Å:- Chain A: R.141
- Chain B: E.119, R.122, K.123, T.126
Ligand excluded by PLIP- 28 x ACT: ACETATE ION(Non-functional Binders)
ACT.10: 5 residues within 4Å:- Chain A: Q.52, T.73, N.74
- Ligands: ACT.19, ACT.20
Ligand excluded by PLIPACT.11: 3 residues within 4Å:- Chain A: G.87, I.88, N.89
Ligand excluded by PLIPACT.12: 3 residues within 4Å:- Chain A: S.186, L.187, Y.188
Ligand excluded by PLIPACT.13: 3 residues within 4Å:- Chain A: S.150, R.264
- Ligands: ACT.15
Ligand excluded by PLIPACT.14: 5 residues within 4Å:- Chain A: V.28, T.29, T.30, E.33, K.50
Ligand excluded by PLIPACT.15: 4 residues within 4Å:- Chain A: D.261, R.264
- Ligands: GOL.7, ACT.13
Ligand excluded by PLIPACT.16: 2 residues within 4Å:- Chain A: K.230, Y.240
Ligand excluded by PLIPACT.17: 3 residues within 4Å:- Chain A: S.199, P.200, S.201
Ligand excluded by PLIPACT.18: 6 residues within 4Å:- Chain A: S.38, H.39, H.63, L.64, E.66, I.192
Ligand excluded by PLIPACT.19: 3 residues within 4Å:- Chain A: K.70, Y.71
- Ligands: ACT.10
Ligand excluded by PLIPACT.20: 2 residues within 4Å:- Chain A: N.74
- Ligands: ACT.10
Ligand excluded by PLIPACT.21: 2 residues within 4Å:- Chain A: N.193, R.198
Ligand excluded by PLIPACT.22: 3 residues within 4Å:- Chain A: E.33, N.36
- Ligands: GOL.5
Ligand excluded by PLIPACT.23: 4 residues within 4Å:- Chain A: Y.245, S.250, K.251, G.254
Ligand excluded by PLIPACT.34: 5 residues within 4Å:- Chain B: Q.52, T.73, N.74
- Ligands: ACT.43, ACT.44
Ligand excluded by PLIPACT.35: 3 residues within 4Å:- Chain B: G.87, I.88, N.89
Ligand excluded by PLIPACT.36: 3 residues within 4Å:- Chain B: S.186, L.187, Y.188
Ligand excluded by PLIPACT.37: 3 residues within 4Å:- Chain B: S.150, R.264
- Ligands: ACT.39
Ligand excluded by PLIPACT.38: 5 residues within 4Å:- Chain B: V.28, T.29, T.30, E.33, K.50
Ligand excluded by PLIPACT.39: 4 residues within 4Å:- Chain B: D.261, R.264
- Ligands: GOL.31, ACT.37
Ligand excluded by PLIPACT.40: 2 residues within 4Å:- Chain B: K.230, Y.240
Ligand excluded by PLIPACT.41: 3 residues within 4Å:- Chain B: S.199, P.200, S.201
Ligand excluded by PLIPACT.42: 6 residues within 4Å:- Chain B: S.38, H.39, H.63, L.64, E.66, I.192
Ligand excluded by PLIPACT.43: 3 residues within 4Å:- Chain B: K.70, Y.71
- Ligands: ACT.34
Ligand excluded by PLIPACT.44: 2 residues within 4Å:- Chain B: N.74
- Ligands: ACT.34
Ligand excluded by PLIPACT.45: 2 residues within 4Å:- Chain B: N.193, R.198
Ligand excluded by PLIPACT.46: 3 residues within 4Å:- Chain B: E.33, N.36
- Ligands: GOL.29
Ligand excluded by PLIPACT.47: 4 residues within 4Å:- Chain B: Y.245, S.250, K.251, G.254
Ligand excluded by PLIP- 2 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Saini, G. et al., The analysis of subtle internal communications through mutation studies in periplasmic metal uptake protein CLas-ZnuA2. J. Struct. Biol. (2018)
- Release Date
- 2018-10-03
- Peptides
- Periplasmic solute binding protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MN: MANGANESE (II) ION(Non-covalent)
- 16 x GOL: GLYCEROL(Non-functional Binders)
- 28 x ACT: ACETATE ION(Non-functional Binders)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Saini, G. et al., The analysis of subtle internal communications through mutation studies in periplasmic metal uptake protein CLas-ZnuA2. J. Struct. Biol. (2018)
- Release Date
- 2018-10-03
- Peptides
- Periplasmic solute binding protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A